High CD34+cell dose is associated with increased early mortality after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Neumann, K. [1 ]
Lange, S. [1 ]
Kragl, B. [1 ]
Glass, Ae [2 ]
Grosse-Thie, C. [1 ]
Wittke, C. [1 ]
Freitag, S. [1 ]
Henze, L. [1 ]
Kleine, H. -D [3 ]
Junghanss, C. [1 ]
机构：
[1] Univ Rostock, Med Ctr, Dept Med, Clin Hematol Oncol Palliat Care 3, Rostock, Germany
[2] Inst Biostat & Informat Med & Ageing Res, Rostock, Germany
[3] Seracell Stammzelltechnol GmbH, Rostock, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P268
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Impact of CD34+stem cell dose on early mortality after allogeneic hematopoietic stem cell transplantation
    Neumann, K.
    Lange, S.
    Kragl, B.
    Glass, A.
    Grosse-Thie, C.
    Wittke, C.
    Freitag, S.
    Henze, L.
    Kleine, H. -D.
    Junghanss, C.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S567 - S567
  • [2] Optimizing the CD34+cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation
    Mehta, Jayesh
    Frankfurt, Olga
    Altman, Jessica
    Evens, Andrew
    Tallman, Martin
    Gordon, Leo
    Williams, Stephanie
    Winter, Jane
    Krishnamurthy, Jairam
    Duffey, Sara
    Singh, Veerpal
    Meagher, Richard
    Grinblatt, David
    Kaminer, Lynne
    Singhal, Seema
    [J]. LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1434 - 1441
  • [3] Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+cell dose
    Reshef, Ran
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01)
  • [4] Effect of CD34+cell dose on clinical outcomes after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Pedraza, A.
    Salas, M. Q.
    Rodriguez-Lobato, L. G.
    Charry, P.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Domenech, A.
    Solano, M. T.
    Arcarons, J.
    Llobet, N.
    Cid, J.
    Lozano, M.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    Rovira, M.
    Martinez, C.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 400 - 400
  • [5] Optimizing the CD34+Cell Dose for Allogeneic Transplantation.
    Mehta, J.
    Evens, Andrew M.
    Altman, J.
    Frankfurt, O.
    Tallman, Martin
    Gordon, L.
    Williams, S.
    Winter, J.
    Krishnamurthy, J.
    Duffey, S.
    Singh, V.
    Meagher, R.
    Singhal, S.
    [J]. BLOOD, 2008, 112 (11) : 408 - 409
  • [6] Effect of CD34+Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
    Pedraza, Alexandra
    Queralt Salas, Maria
    Gerardo Rodriguez-Lobato, Luis
    Charry, Paola
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Domenech, Ariadna
    Teresa Solano, Maria
    Arcarons, Jordi
    de Llobet, Noemi
    Rosinol, Laura
    Gutierrez-Garcia, Gonzalo
    Fernandez Aviles, Francesc
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Martinez, Carmen
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (03): : 181.e1 - 181.e10
  • [7] Impact of transplanted CD34+cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    Sohn, SK
    Kim, JG
    Kim, DH
    Lee, NY
    Suh, JS
    Lee, KB
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 967 - 972
  • [8] Ideal or actual body weight to calculate CD34+cell doses for allogeneic hematopoietic stem cell transplantation?
    Cilley, J
    Rihn, C
    Monreal, J
    Gordon, LI
    Singhal, S
    Tallman, M
    Williams, S
    Winter, J
    Mehta, J
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 (02) : 161 - 164
  • [9] Effect of CD34+cell dose on outcome of allogeneic hematopoietic stem cell with myelodysplastic syndrome in children and adolescents
    Osipova, A.
    Afanasyev, B.
    Zubarovskaya, L.
    Semenova, E.
    Bykova, T.
    Razumova, S.
    Borovkova, A.
    Kojokar, P.
    Paina, O.
    Morozova, E.
    Ovetchkina, V.
    Alyanskiy, A.
    Babenko, E.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S476 - S476
  • [10] Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Remberger, Mats
    Torlen, Johan
    Ringden, E.
    Engstrom, Mats
    Watz, Emma
    Uhlin, Michael
    Mattsson, Jonas
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 889 - 893
12345